NCT02514447 2025-09-25Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan ChemotherapyG1 Therapeutics, Inc.Phase 1/2 Completed123 enrolled 46 charts
NCT02499770 2020-08-21Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)G1 Therapeutics, Inc.Phase 1/2 Completed122 enrolled 62 charts